ACTIVITY TITLE: Mental Health Professional Certificate Course Part 2: Treatment Interventions
CREDIT DESIGNATION STATEMENT
The American Society for Reproductive Medicine designates this enduring material for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Mental Health Professionals Group of the American Society for Reproductive Medicine is approved by the American Psychological Association to sponsor continuing education for psychologists. This Activity will offer 6.75 continuing education credits. The Mental Health Professionals Group of the American Society for Reproductive Medicine maintains responsibility for this program and its content.
Release Date: June 1, 2017
Expiration Date: June 1, 2020
Estimated Time to Complete Activity: 6.75 hours
NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP
Mental Health Professionals experience significant challenges when working in reproductive medicine. The competence required to practice in this area does not carry over from other mental health care settings. Treatment interventions that take into consideration the scientific, medical, and psychological aspects of infertility treatments must be designed and/or adapted specifically for infertility patients. As new treatments evolve, complex ethical and legal/regulatory issues arise. Psychological research must be rigorous and suitably designed to address the unique questions in this field. Part 2 of the Mental Health Professional Certificate Course provides an opportunity for mental health practitioners to be introduced to and understand treatment interventions, ethics, fertility preservation and research in assisted reproductive technology. Successful completion of Part 1, Mental Health Professional Certificate Course: Basic Infertility is a prerequisite to this course.
Completion of the MHPG Certificate Course or any of its components does not provide credentials to practice as a mental health professional in the assisted reproductive technology setting.
At the conclusion of the educational activity, participants should be able to:
1. Analyze and apply ethical principles in treating patients using assisted reproductive technologies (ART).
2. Identify treatment interventions that are relevant for patients in ART.
3. Apply the basic principles of research applicable to ART psychological paradigms.
Lesson 1 Ethical Practices in Fertility Counseling
Lesson 2 Cognitive and DBT Informed Behavioral Therapy for Infertility
Lesson 3 Couple Counseling in Infertility: Emotionally Focused Therapy (EFT)
Lesson 4 The Intersection of Sexual Function and Infertility
Lesson 5 Infertility and Grief Counseling
Lesson 6 Stress Management and Coping: Approaches to Working with the Infertility Patient
Lesson 7 Antidepressant Therapy during Assisted Reproductive Technology and Pregnancy
Lesson 8 Psychosocial Research in Assisted Reproductive Technology (ART)
Lesson 9 The Role of Mental Health Professionals in Adult Fertility Preservation
This activity has been designed to meet the educational needs of mental health professionals involved in infertility care.
Interpersonal and Communication Skills
SUCCESSFUL COMPLETION REQUIREMENTS
Successful completion of this activity requires the learner to:
Successfully complete Part 1 of the Mental Health Professional Certificate Course: Basic Infertility (MHPCC001).
View a course overview page, containing all CME and disclosure information, including acknowledgement of any commercial support and disclosure of unlabeled use, prior to the start of each module.
Complete a 10-question pre-exam prior to each module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.
Be given the option of downloading a printed syllabus containing the presentation and narrative.
Participate in the interactive activity: Audio narration is synchronized with PowerPoint presentation that can be advanced, stopped or reversed as desired.
· After completion of all 9 modules, take a 90-question post-exam, with feedback of correct/incorrect answers, scoring a minimum of 75% in two attempts.
· Complete the evaluation survey.
· Print certificate of completion.
DISCLOSURES FOR PLANNERS AND FACULTY
Nancy A. Bowers, BSN, RN, MPH - Nothing to Disclose
Susan A. Gitlin, PhD – Nothing to Disclose
Shelley Lee, PhD – Nothing to Disclose
Content Developers and Reviewers
· Jean Benward, MSW – Nothing to Disclose
· Kris Bevilacqua, PhD – Nothing to Disclose
· Julie Bindeman, PsyD – Nothing to Disclose
· Andrea Braverman, PhD – Nothing to Disclose
· Shara Brofman, PhD – CVS Stock ownership
· Nicole Cirino, MD – Nothing to Disclose
· Bonnie Cochran, LCSW – Nothing to Disclose
· Alice Domar, PhD – Consultant: Merck, Ferring, Ovascience; Ownership/Stock: TriaDea Integrative Health Center and FertiCalm
· Amanda Ellis, RN, BSN – Nothing to Disclose
· Allison Fagan, PhD – Spouse is on Speaker's Bureau: AstraZeneca, Allergan, Mylan
· Nancy Freeman-Carroll, PsyD – Nothing to Disclose
· Joann Galst, PhD – Nothing to Disclose
· Elizabeth Grill, PsyD Co Owner: FertiCalm, AlizHealthcare
· Judith Horowitz, PhD – Nothing to Disclose
· Danielle Kaplan, PhD – Nothing to Disclose
· Daniel Kaser, MD – Nothing to Disclose
· Sheryl Kingsberg, PhD – Paid consultant: Valeant, Acerus, Emotional Brain, Pfizer, Shionogi, Sermonix, NovoNordisk, Perrigo, Nuelle, Materna, Palatin; Stock options: Viveve
· Sue Klock, PhD – ForsMarsh LLC
· Angela Lawson, PhD – Nothing to Disclose
· Piave Lake, MD – Nothing to Disclose
· Shelley Lee, PhD – Nothing to Disclose
· Lauri Pasch, PhD – Nothing to Disclose
· Debra Reuben, PhD – Nothing to Disclose
· Mindy Schiffman, PhD – Nothing to Disclose
· Carly Snyder, MD – Speaker: Sage Therapeutics
· Irene Souter, MD – Nothing to Disclose
· Margot Weinshel, LCSW, RN – Nothing to Disclose
· Julianne E. Zweifel, PhD – Nothing to Disclose
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity are expected to disclose any relationships they may have with companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.
This CME activity is sponsored by the American Society for Reproductive Medicine.
STATEMENT OF SUPPORT
No commercial support was provided for this activity.